# Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects

> **NCT02641990** · PHASE1 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 28 (actual)

## Conditions studied

- Healthy Adult Premenopausal Female Volunteers

## Interventions

- **DRUG:** ITCA 650 20/60 mcg/day, ITCA placebo
- **DRUG:** ITCA placebo, ITCA 650 20/60 mcg/day

## Key facts

- **NCT ID:** NCT02641990
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02641990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02641990, "Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02641990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*